Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

UCSF researchers are the first to demonstrate that the approach works for the patients who need it the most.Patients who struggle to take daily HIV ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...

Home-based HIV counseling and relationship building improved HIV testing, diagnoses and viral suppression among pregnant ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline ...

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

Opens in a new tab or window SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) avoided rebound for 5 ...

As Japan marked World AIDS Day on Dec. 1, a workplace incident showed that patients in the ... because he or she has HIV. Companies are also asked to keep such information strictly confidential.